Skip to main content

Tech Firm Fluence Analytics Moves HQ to Stafford

Published Sep 16, 2021 by David Ruiz

Digital Tech Trends

Houston Inno recently reported technology firm Fluence Analytics relocated its headquarters from New Orleans to Stafford last month. The company joins Hewlett Packard Enterprise, NRG Energy and other companies who have relocated their headquarters to the Bayou City this year

Fluence Analytics, which develops industrial and laboratory products for polymer manufacturers, recently closed a financing round of $7.5 million. The funding will assist in improving production of its next-generation Automatic Continuous Online Monitoring of Polymerization Reactions (ACOMP) systems. Houston Inno reported the firm will also increase its headcount.

Fluence Analytics is also partnering with Tokyo-based Yokogawa Electric Corporation, whose North American headquarters are located in Sugar Land. Under the exclusive agreement, Yokogawa will be Fluence Analytics’ exclusive distributor of ACOMP systems in Asia, the Middle East and North Africa. The partnership will also bring proximity advantages for distribution and potential business from Houston’s market. Fluence Analytics CEO Alex Reed said the company works with energy and petrochemical clients, making Houston the ideal place for its headquarters. He also noted Houston’s highly skilled workforce. 

“There are very, very good people in the Houston area with a lot of diverse experience — oil and gas, petrochemicals, all the service companies, a lot of the contractors and fab shops that we would work with," Reed said. "Infrastructure is huge, and if you look at Houston, it's got everything you need.”

Founded in 2015, Fluence Analytics will maintain a presence in New Orleans, mainly focused on research and development. 

With nearly 244,000 tech workers, Houston has the 11th largest tech workforce in the U.S., more workers than Austin and Denver. Houston’s tech startups raised over $820 million in venture capital last year. 

Learn more about relocations to our region and Houston’s digital tech sector. Learn what makes Houston an attractive place for headquarters

Related News

Life Sciences

One Year In, TMC’s Helix Park Proves to be a Powerful Innovation Hub

11/7/24
Nearly one year since launching its first phase, the Texas Medical Center’s Helix Park is already proving to be a powerful catalyst for innovation, attracting a range of life sciences companies and bolstering collaboration between industry and academia.   The 37-acre campus opened with the TMC3 Collaborative Building and Dynamic One Building, now home to prestigious institutions like Baylor College of Medicine, MD Anderson Cancer Center, Houston Methodist, Texas A&M University and UTHealth. Chicago-based venture capital firm Portal Innovations also joined the campus last year, occupying the entire third floor of the Collaborative Building with a 30,000-square-foot space.  Growth continues at Helix Park as local institutions and companies expand their research initiatives and establish a stronger presence on campus. Rice University recently launched RBL LLC, a venture creation studio designed to act as a direct pipeline for new companies built around the technologies developed at its Biotech Launch Pad, established last year.   “Leveraging Rice University’s Biotech Launch Pad breakthroughs and pairing it with the world-class translational infrastructure of TMC Helix Park well positions RBL to drive unprecedented advances in patient care,” said William McKeon, President and CEO of TMC, in a statement. “This partnership between academia, industry and health care is exactly what’s needed to transform medical discoveries into real-world solutions that improve lives globally.”  In September, March Biosciences, an emerging clinical-stage biotech company spun off from Baylor College of Medicine, Houston Methodist Hospital, and Texas Children’s Hospital’s Center for Cell and Gene Therapy, moved to the Helix Park campus. Shortly after the move, March Biosciences successfully closed an oversubscribed $28.4 million Series A financing round. This funding will support the Phase 2 clinical development of MB-105, the company’s innovative cancer-fighting therapy.   Switzerland-based biotech company Artidis also recently expanded to Helix Park, securing 2,000 square feet in Portal Innovations’ suite within the Collaborative Building, according to the Houston Business Journal. The company uses nanotechnology to rapidly diagnose cancer and develop personalized treatment plans.  MD Anderson Cancer Center is also increasing its footprint at TMC with a new $239 million, 281,254-square-foot research facility featuring lab and office space. According to the Houston Business Journal, the facility, set for completion in 2028, will focus on advancing preclinical research.  Additionally, the campus welcomed its first restaurant, Ojo de Agua, which offers a blend of Mexican and Mediterranean cuisine, contributing to Helix Park’s vision of becoming a premier destination.  “We are excited to introduce Ojo de Agua to the Texas Medical Center community and present a new spot where members and visitors can connect, celebrate and collaborate while enjoying a unique culinary experience,” said McKeon in a statement. “Food has a way of bringing people together and as our campus continues to welcome visitors from all over the world, Ojo de Agua will showcase high quality, fresh ingredients that reflect the vibrancy and diversity of our community.”  Learn more about the growth happening at TMC at the Partnership’s State of the Texas Medical Center event on November 14. 
Read More
Health Care

University of Houston, Baylor College of Medicine to Launch Cutting-Edge Research Hub

8/26/24
The University of Houston (UH) and Baylor College of Medicine (BCM) have been awarded a $44.2 million grant from the National Center for Advancing Translational Research. This funding will support the establishment of a regional hub dedicated to advancing clinical and translational research.  Dubbed the Consortium for Translational and Precision Health (CTPH), the new hub will enhance collaboration between the two institutions and other clinical and research groups within the Texas Medical Center. The CTPH aims to expedite the translation of new technologies and discoveries into patient care and real-world impact, provide funding and resources to accelerate pilot projects and research initiatives and connect investigators with local healthcare organizations and government agencies that are dedicated to healthcare, clinical research and policy.  “Research is the engine empowering health care’s life-changing advancements,” said UH President Renu Khator, in a release. “This innovative hub will be a catalyst for groundbreaking discoveries and treatments that improve people’s quality of life. That’s what drives us at UH and we’re ecstatic to cofound a regional hub for change alongside Baylor.”  The hub will be led by BCM’s Christopher Amos, professor and director of the Institute for Clinical and Translational Research, and Dr. Fasiha Kanwal, professor of medicine and chief of the section of gastroenterology and hepatology, alongside UH’s Dr. Bettina M. Beech, clinical professor of population health and chief population health officer.  “The CTPH is a partnership that draws on strengths of both institutions, creating a rich multidisciplinary environment. It will act as the vehicle to enhance the infrastructure and resources needed to effectively conduct research and implement solutions to advance healthcare,” said Dr. Carolyn Smith, interim senior vice president and dean of research at BCM. “It will help implement and create ongoing core research activities that will support the clinical translational science at both institutions.”  This strategic partnership comes at a time when local institutions are intensifying efforts to advance critical research that will deliver vital healthcare solutions. The University of Texas MD Anderson Cancer Center and Rice University recently announced a collaboration to advance fundamental and translational cancer research and develop life-saving technologies. Additionally, a research initiative led by Rice University, in collaboration with MD Anderson, received an $18 million grant to improve tumor removal technology for breast, head and neck cancer.  Learn more about Houston’s Life Sciences industry. 
Read More

Related Events

Economic Development

Regions featuring San Jacinto College Center For Petrochemical, Energy, and Technology

Join the Partnership for an Exclusive Experience at the San Jacinto College Center for Petrochemical, Energy, and Technology! Discover why the San Jacinto College Center for Petrochemical,…

Learn More
Learn More
Executive Partners